Cargando…
Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Ltd.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834467/ https://www.ncbi.nlm.nih.gov/pubmed/33521673 http://dx.doi.org/10.1016/S2665-9913(20)30424-0 |
| _version_ | 1783642287294644224 |
|---|---|
| author | Vlaar, Alexander P J de Bruin, Sanne Brouwer, Matthijs C van de Beek, Diederik |
| author_facet | Vlaar, Alexander P J de Bruin, Sanne Brouwer, Matthijs C van de Beek, Diederik |
| author_sort | Vlaar, Alexander P J |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7834467 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-78344672021-01-26 Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply Vlaar, Alexander P J de Bruin, Sanne Brouwer, Matthijs C van de Beek, Diederik Lancet Rheumatol Correspondence Elsevier Ltd. 2021-02 2020-12-14 /pmc/articles/PMC7834467/ /pubmed/33521673 http://dx.doi.org/10.1016/S2665-9913(20)30424-0 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Vlaar, Alexander P J de Bruin, Sanne Brouwer, Matthijs C van de Beek, Diederik Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title | Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title_full | Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title_fullStr | Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title_full_unstemmed | Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title_short | Efficacy matters: broadening complement inhibition in COVID-19 – Authors' reply |
| title_sort | efficacy matters: broadening complement inhibition in covid-19 – authors' reply |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834467/ https://www.ncbi.nlm.nih.gov/pubmed/33521673 http://dx.doi.org/10.1016/S2665-9913(20)30424-0 |
| work_keys_str_mv | AT vlaaralexanderpj efficacymattersbroadeningcomplementinhibitionincovid19authorsreply AT debruinsanne efficacymattersbroadeningcomplementinhibitionincovid19authorsreply AT brouwermatthijsc efficacymattersbroadeningcomplementinhibitionincovid19authorsreply AT vandebeekdiederik efficacymattersbroadeningcomplementinhibitionincovid19authorsreply |